Microbix Biosystems Inc T.MBX

Alternate Symbol(s): MBXBF

Healthcare Biotechnology

Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Its segments include development, manufacturing and sales of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and, and development and commercialization of novel and proprietary products or technologies, such as Kinlytic. Its Kinlytic urokinase is a biologic thrombolytic drug used to treat blood clots.

TSX:MBX - Post by User

Microbix Biosystems Inc

Bullboard Posts

Post by amendison Jun 28, 2015 5:36pm

134 Views

Post# 23875522

I am very sorry to hear

Rovaniemirover post is very sad. He or she long time investor, and a bull board poster. very sad about the management. Way I read I hope I understand Wong. One day MBX gives fruit. If Bill Gastal leaves the management it is better for MBX. But he owns 20% or more his family. He started company. During my time all deals he was in are fail. China and Sydus are best one. So many detail didn't give to the market to, sp go up. This profitable core should stay above $1.25. No wonder every one frustrated. I hope management do deals soon. worst news relies we can hear CEO panatony quit. some time people can not work together.

Bullboard Posts

A potential breakthrough in spinal cord and optic nerve injury treatment